-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。当社は、12ヶ月後の目標株価を50ドル(2026年EPS予想の22倍)に据え置きます。この倍率は、ZGの過去3年間の平均である40倍を下回っていますが、これはFTC(連邦取引委員会)による独占禁止法調査の影響を適切に反映していると考えています。しかしながら、当社のEPS予想モデルは、ZGの戦略が引き続き力強く実行されると予測しています。市場シェアの拡大とレンタル事業の好調な成長に牽引され、2026年の売上高は29億8,100万ドル(15.4%増)になると予測しています。2026年のEBITDAマージンは25.3%と予測しており、これは130ベーシスポイントの拡大に相当します。この拡大は、上半期に多額の法的費用とマーケティング費用が減少する下半期に大きく影響すると考えられます。 2026年のEPS予想を2.00ドルから2.27ドルに、2027年のEPS予想を2.50ドルから3.00ドルに引き上げました。最終的に、ZGの株価は50%のディスカウントで取引されており、魅力的なエントリーポイントとなっています。市場は短期的な訴訟やマクロ経済の逆風に過度に注目し、住宅市場の正常化に伴いZGが事業を継続的に展開していく中で、AIによって加速される収益力を過小評価していると考えています。
Related Articles
Teva Pharmaceutical Industries Insider Sold Shares Worth $384,444, According to a Recent SEC Filing
Amir Weiss, Chief Accounting Officer, on May 06, 2026, sold 10,679 shares in Teva Pharmaceutical Industries (TEVA) for $384,444. Following the Form 4 filing with the SEC, Weiss has control over a total of 20,016 ordinary shares of the company, with 20,016 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/818686/000119312526211855/xslF345X05/ownership.xml
Research Alert: CFRA Maintains Buy Opinion On Shares Of Doordash, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $2 to $240, based on 30x our 2027 EPS view, just below DASH's three-year average (~32x) given competitive threats from AI and Uber Eats, offset by the company's dominant market position and positive network effects. We raise our 2026 adjusted EPS view by $0.10 to $5.63 and 2027's by $0.06 to $7.99. We are encouraged by DASH's Q2 Marketplace GOV guidance (+36% Y/Y), an encouraging result following relatively soft guidance for Q1, especially given fears of a weakening consumer. International sales continue to scale solidly, with Deliveroo accelerating to 14% Y/Y growth in Q1 vs. 7% growth in Q4 (we expect continued improvement all year). Margin pressure remains (adjusted EBITDA margin -20 bps Y/Y to 2.4%) but should fade as platform integration activities finish up early next year. Adjusted EBITDA guidance (midpoint of $820M) was above expectations ($742M), despite the company expecting another $50M gas relief charge, which should persist amid the Strait of Hormuz closure.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Tyson Foods, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target remains $76, a 15x multiple of projected FY 27 EPS of $5.09 (raised by $0.02). We also lift our FY 26 (Sep.) EPS est. by $0.09 to $4.11. This multiple is slightly above TSN's long-term average of 14x, reflecting favorable secular tailwinds, including a continued shift in consumer preferences toward protein and improved earnings growth potential as the Beef segment recovers, likely in FY 27. Operationally, TSN is executing well, particularly in Chicken, where margins continue to widen, up 290 bps year over year in FQ2. Beef remains pressured by historically tight cattle supplies, with the U.S. herd at its lowest level since 1951, though we expect margins to improve following recent restructuring actions, including rightsizing production to improve capacity utilization. TSN's balance sheet is solid, noting its leverage ratio (net debt/adjusted EBITDA) has now improved to 2.2x vs. 3.9x two years ago. This provides a decent degree of financial flexibility in our view.